- Advertisement -

Downstream Bottlenecks are Slowing mAbs Manufacturing: This New TFF Tech Can Help

Sponsored content brought to you by For decades, therapeutic monoclonal antibody (mAb) production relied on traditional batch-based manufacturing using stainless steel systems. But as biopharmaceutical...

Flu Vaccine Strategy Pairs Injection and Nasal Spray, Shows Promise in Pigs

In a study headed by researchers at the Institute of Virology and Immunology (IVI) in Mittelhäusern, a new, two-step flu vaccination strategy that pairs...

Accelerating mRNA-LNP Formulation Screening for Genomic Drug Discovery and Development

REGISTER NOW Panelists: Arpan DesaiManaging DirectorNanoVation Therapeutics UK Graham Hayes, PhDSenior ScientistNanoVation Therapeutics UK Ben Knappett, PhDProduct Manager, LNP SolutionsUnchained Labs ...

Effect of COVID-19 Antiviral Remdesivir Multiplied 10-Fold by Hepatitis C Drugs

Remdesivir, the only antiviral drug approved in the United States for treating COVID-19 patients, is up to 10 times more effective when it is...

Infectious Disease Experts Proclaim “Many Voices, One Health”

Surveillance Perspectives – Part I NORTH AMERICA, AFRICA, EUROPE By David Levine   Since IMED 2018—the 7th International Meeting on Emerging Diseases and Surveillance—the world has seen...

From Tools to Trials: Editing Therapy Companies Pivot to Development

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to address the longtime challenge of bringing...

New ‘heart-on-a-chip’ to halt cardiac damage caused by Duchenne

Duchenne Parent Project Spain (DPPE) has launched the BEAT Project, a research initiative focused on one of the key challenges associated with Duchenne and...

From Discovery to GMP: Building Scalable Cell Therapy Manufacturing

Read NowOver the past decade, our industry has witnessed the promise of cell and gene therapies. Patients with rare diseases or hard-to-treat diagnoses now...

New ‘heart-on-a-chip’ to halt cardiac damage caused by Duchenne

Duchenne Parent Project Spain (DPPE) has launched the BEAT Project, a research initiative focused on one of the key challenges associated with Duchenne and...

From Discovery to GMP: Building Scalable Cell Therapy Manufacturing

Read NowOver the past decade, our industry has witnessed the promise of cell and gene therapies. Patients with rare diseases or hard-to-treat diagnoses now...

Obesity and Alzheimer’s linked through early metabolic disruptions

By 2030, the population in the United States aged 65 and older is expected to reach 71 million or about 20% of Americans. This...

more new items

New ‘heart-on-a-chip’ to halt cardiac damage caused by Duchenne

Duchenne Parent Project Spain (DPPE) has launched the BEAT Project, a research initiative focused on one of the key challenges associated with Duchenne and...

From Discovery to GMP: Building Scalable Cell Therapy Manufacturing

Read NowOver the past decade, our industry has witnessed the promise of cell and gene therapies. Patients with rare diseases or hard-to-treat diagnoses now...

Obesity and Alzheimer’s linked through early metabolic disruptions

By 2030, the population in the United States aged 65 and older is expected to reach 71 million or about 20% of Americans. This...